Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Consolidated Net Income (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Consolidated Net Income data on record, last reported at -$18000.0 in Q2 2024.

  • For Q2 2024, Consolidated Net Income rose 99.21% year-over-year to -$18000.0; the TTM value through Feb 2025 reached -$18000.0, down 104.58%, while the annual FY2024 figure was $2.7 million, 107.59% up from the prior year.
  • Consolidated Net Income reached -$18000.0 in Q2 2024 per LFCR's latest filing, down from $847000.0 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $1.9 million in Q3 2023 and bottomed at -$25.2 million in Q1 2023.
  • Average Consolidated Net Income over 5 years is -$5.9 million, with a median of -$2.9 million recorded in 2021.
  • Peak YoY movement for Consolidated Net Income: tumbled 59134.29% in 2020, then soared 143.58% in 2023.
  • A 5-year view of Consolidated Net Income shows it stood at -$8.4 million in 2020, then skyrocketed by 115.16% to $1.3 million in 2021, then plummeted by 383.41% to -$3.6 million in 2022, then skyrocketed by 99.33% to -$24000.0 in 2023, then grew by 25.0% to -$18000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Consolidated Net Income were -$18000.0 in Q2 2024, $847000.0 in Q1 2024, and -$24000.0 in Q4 2023.